Digital Biometric Measures in Long COVID: A Secondary Analysis of the STOP-PASC Randomized Clinical Trial.

JAMA Netw Open · 2025 · PMC12355292 · PMID 40810942

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While the nirmatrelvir-ritonavir arm tended to exhibit slightly greater changes from baseline compared with the placebo-ritonavir arm in most weeks, these differences did not reach statistical significance (eFigures 2 and 3 in Supplement 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.